3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
39
Ovarian Neoplasms
29
Multiple Myeloma
16
Neoplasms
9
Recurrence
8
Lymphoma
8
Fallopian Tube Neoplasms
8
Triple Negative Breast Neoplasms
7
Lymphoma, Large B-Cell, Diffuse
7
Hodgkin Disease
7
Carcinoma, Ovarian Epithelial
7
Lymphoma, Non-Hodgkin
6
Sarcoma
5
Neoplasm Metastasis
5
Burkitt Lymphoma
3
Uterine Cervical Neoplasms
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Mesothelioma, Malignant
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Lung Neoplasms
2
Liver Neoplasms
2
Leukemia
2
Leiomyosarcoma
2
Kidney Neoplasms
2
Endometrial Neoplasms
2
Disease Progression
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Interventions
Radiotherapy
4
fludarabine phosphate
2
aldesleukin
2
Paclitaxel
2
Nivolumab
2
Bevacizumab
2
zimberelimab
1
rocakinogene sifuplasmid
1
liposomal doxorubicin
1
fludarabine
1
durvalumab
1
dostarlimab
1
belzutifan
1
alovudine
1
Watchful Waiting
1
Vaccines, Synthetic
1
VGX-3100
1
Therapeutic Touch
1
Specimen Handling
1
Ritonavir
1
Radiosurgery
1
Radiation
1
Peripheral Blood Stem Cell Transplantation
1
Papillomavirus Vaccines
1
Observation
1
Mycophenolic Acid
1
Magnetic Resonance Spectroscopy
1
MEDI0457
1
Ipilimumab
1
Indinavir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Vaginal Neoplasms
×
liposomal doxorubicin
×
Clear all
NCT06023862
2026-05-06
DOVE
Yonsei University
Phase 2
Recruiting
198 enrolled